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Abstract:
Secondary echinococcosis is an important
complication of hydatid disease and is not
rare in the peritoneal cavity. However, the
frequency of secondary hydatidosis in the
pleural cavity is not very well known.
This study was planned to elicit the frequency
of secondary cyst development in the pleural
cavity, and to compare this with secondary
peritoneal hydatidosis. It was also intended to
follow up cyst development by serological
tests.
Twelve white female Island rabbits were
used. The mean weight of the rabbits was
2450±420 g. Cystic fluid containing
protoscolex, hydatid sand and germinative
membrane homogenate was injected via an
18 F needle into the pleural and peritoneal
cavities of the rabbits. At the begining and
the fourth and fifteenth weeks of the study,
5 cc of blood was withdrawn from the ear
veins of the rabbits for serological
investigations. All rabbits were sacrified by
cervical dislocation at the end of the fifteenth
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Introduction
Although cystic hydatid disease has been entirely
eradicated in some countries, it remains a serious health
problem in certain parts of the world. It is endemic in the
Middle East and the Balcanic countries including Turkey.
Spread of cystic hydatid disease can be attributed to
continual migration.
Man is an incidental intermediate host, inseminated by
the parasite frequently through the ingestion of the ova
and rarely by inhalation. The hegzegant embryo becomes
free after digestion of the ova in the gastrointestinal tract
and the resultant embryo most often settles down in the
liver via the portal circulation. The embryo, which passes
through the liver and crosses to the lymphatic system,

week of the study. Peritoneal and pleural
cavities were opened and examined for
secondary cyst development. Serological
investigations were performed with indirect
hemaglutination and indirect flourescein
antibody tests.
The frequency of secondary echinococcosis in
the peritoneal cavity was 80% and, in the
pleural cavity 30 %. In determining the
antibodies against the hydatid antigens the
indirect flourescein antibody test was more
sensitive than the indirect hemaglutination
test.
The occurence of secondary echinococcosis is
possible in the pleural cavity, but to a lesser
degree than in the peritoneal cavity. Indirect
hemaglutination and indirect flourescein
antibody tests were found to be valuable
serological tools for the diagnosis of hydatid
disease.
Hydatid cyst, secondary echinococcosis,
pleural and peritoneal cavities, IHA and IFA
tests.

then enters the systemic circulation and may involve
various organs where it can cause cystic hydatid
disease(1).
Germinative membrane and scolex have the potential
of new or secondary cyst formation (1-3). The most
important and occasional complication of the hydatid cyst
is spontaneous, traumatic, or operative rupture into the
pleural or peritoneal cavity to seed for secondary
echinococcosis (4-11).
Secondary echinococcosis is not rare in the peritoneal
cavity after the rupture of a primary cyst such as liver,
spleen, kidney or intra-abdominally located hydatid cysts,
usually resulting in secondary echinococcosis in the
peritoneal cavity (1, 4, 7, 11-13). However, the

* This study was carried out at Erciyes University Medical Research Center, Kayseri, Turkey.
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frequency and the mechanism of secondary hydatidosis in
the pleural cavity is not very well known. There are many
contraversial findings and reports about this event (1, 14
-17).
This study was designed and carried out to determine
whether a secondary cyst can develop in the pleural
cavity, and if so, to determine its frequency and to
compare it with peritoneal hydatidosis. It was also
intended to utilise serological tests to follow up cyst
development in the experimental animals.
Materials and Methods
Twelve white female island rabbits were used in this
study. The mean weight of the rabbits was 2450±420 g.
Hydatid cyst containing sheep livers were obtained
from the Kayseri Meat Institute. Cystic fluid was collected
by aspiration of the cysts under aseptic conditions. In
order to increase the amount of scolex, the fluid was
collected into a 10 cc syringe by back and forth
aspiration. This fluid was put into a sterile centrifuge tube
for 10 minutes. Scoleces precipitated at the bottom of the
tubes and the supernatant fluid was discharged. A drop of
hydatid sand including scoleces was taken with a sterile
pasteur pipette to determine the viability of protoscoleces
under a light microscope (1, 2 ). Germinative membrane
and hydatid sand of the cysts were obtained under sterile
conditions, and prepared by homogenizing to a density
which could be injected.
After the right hemithorax and the abdominal wall of
the rabbits were shaved, 5 cc of blood was withdrawn
from the ear veins and saved for serological tests. 0.5 ml
of fluid containing protoscolex and germinative
membrane and hydatid cyst formation was injected
separately, via an 18F needle into the pleural and
peritoneal cavities of the rabbits. After inoculation, the
rabbits were left in their cages for 15 weeks.
At the fourth and fifteenth weeks of the study, 5 cc of
blood was withdrawn from the ear veins of the rabbits
for serological investigations. At the fifteenth week of the

Table 1.

study, all rabbits were sacrified by cervical dislocation.
The peritoneal and pleural cavities were opened with a
midline laparatomy and sternotomy. The cavities were
examined carefully for hydatid cyst formation. The
number of cysts, their size and location were determined
and recorded. After photographs were taken, all the cysts
were excised and kept in 10 % formaline solution for
histopathological examination.
Serological investigations were performed with
indirect hemaglutination (IHA) and indirect flourescein
antibody (IFA) tests. In the IHA test, the patient’s sera is
mixed with sensitive red blood cells in different titrations
in a tube. In the prescence of antibody in the sera,
irregular precipitation of the sensitive red blood cells
occurs. In the abscence of antibody, the red blood cells
neatly precipitate at the bottom of the tube (18). In the
IFA test, antibodies in the patient’s sera bind to the
antigen particles. This complex binds to the antihuman
gammaglobulin that is marked with florescein
isothiocyanate (18, 19).
Paraffin blocks of the tissue samples were prepared,
stained with haematoxylin-eosin and examined under a
light microscope. Microscopic pictures were taken when
necessary.
Student t test was used for statistical analysis. A p
value of <0.05 was accepted as statistically significant.
Results
Two rabbits died after injection of the cystic fluid and
were excluded from this study, which, therefore, was
completed with ten rabbits.
Secondary echinococcosis developed in the peritoneal
cavities of eight rabbits and in the pleural cavities of three
rabbits (p<0.05). There was no cyst formation in the
peritoneal and pleural cavities of two of the rabbits. The
diameters of the cysts varied between 2 and 8 mm. In
total, there were 39 cysts in the peritoneal cavities of
eight rabbits and 7 cysts in the pleural cavities of three of
the rabbits (Table 1).

Number of cyst in the pleural and peritoneal cavities.

Rabbits No:

1

2

3

4

5

6

7

8

9

10

Cyst Numbers:
Peritoneal Cavity
Pleural Cavity

3
-

4
-

4
-

6
2

5
2

3
-

6
-

-

8
3

-

102

K. KAZEZ, M. ŞAHİN, C. VATANSEV, Y. ARITAŞ, F. AKSOY, H. VATANSEV

Adhesions were noticed in the pleural and peritoneal
cavities of all rabbits, around the injection sites. All of the
peritoneal cysts were located on the intestinal surface and
the parietal peritoneum overlying the abdominal wall
which was punctured with the needle (Figure 1). Pleural
cysts were located on the lower parts of the right lungs
(Figure 2).
There was no positive result with the IHA and IFA
tests in the blood sera of the rabbits withdrawn before
the study. On the basis of these results it was decided that
the rabbits did not have hydatid cysts, or any disease
likely to have cross-reaction with a hydatid cyst, before
the study.
Positive results were detected in 1/4 and 1/16 of the
titrations with the IHA test in the blood sera withdrawn
at the end of the fourth week. There was no antibody
measurement in any titration in the blood sera of the two
rabbits without cysts. In the blood sera withdrawn at the
fifteenth week, antibody measurements showed positive
results in 1/4 and 1/32 titrations in all animals. Antibody
titrations correlated with the number of the cysts and
cyst duration (Table 2).
In the blood sera of the rabbits that was withdrawn at
the fourth week of the study, positive results were
achived at 1/4 and 1/32 titrations with the IFA test in all
animals. Positive results were measured at 1/4 and 1/128
titrations in the blood sera of all animals at the end of the
fifteenth week (Table 3).
Although there was no antibody measurement with
the IHA test in the blood sera of two cyst-free animals at
the fourth week, positive results were achieved with the

IFA test in the same blood samples. It was also noticed
that the IFA test gave positive results in lower titrations
than the IHA test. In spite there being of no cyst
formation, positive results were thought to be due to the
injected cystic content.
For comparison in determining the antibodies against
the hydatid antigens, the IFA test was found to be more
sensitive than the IHA test. The titrations that were
measured with the two tests showed correlation in each
animal.
On histopathological examination, the laminar layer
and germinative membrane were seen in all cysts
(Figure 3).
Discussion
Secondary echinococcosis is a severe complication of
hydatid disease. Although spontaneous or traumatic cyst
rupture and the resultant peritoneal spillage of cystic
contents can cause cyst inoculation, the main cause of
secondary cyst development is due to operative spillage of
the scoleces (1, 9, 15).
When the scoleces, which have the ability of
reproduction and asexual growth, spread, they are usually
eradicated by host defense mechanisms. However, the
scoleces that remain viable can develop secondary cysts
months or even years laters(1).
The incidence of secondary cyst development is not
known for certain. Mottaghian (12) found out that the
incidence of secondary cyst development in his patients,
followed up for 3 to 8 years, was 11.3%. Morris (20)
Figure 1.

Appearence
of
a
peritoneal cyst at fifteenth
week. Cysts located on
the surface of the
intestinal peritoneum.
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noted that the frequency of secondary echinococcosis was
10% in general, but this was 30% in peritoneal
hydatidosis.
The host defense mechanisms, patient’s age, viability,
the number of spilled scoleces and serosal surfaces were
accepted as the most important factors in the
development of secondary echinococcosis (1, 4, 12, 21).
Although serosal surfaces are suitable places for the
adherence and growth of scoleces, it has been suggested
that mucosal surfaces are not suitable places for the
nourishment of scoleces (12). Rupture of cysts into the
bronchus or biliary tract does not lead to development of
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Figure 2.

Appearence of a pleural
cyst at the fifteenth week.
All cysts located on the
lower parts of the lungs.

Figure 3.

Microscopic appearence of
a cross section of a cyst.
One layer of germinative
membrane and laminar
layer is evident (stained
haematoxylin – eosin. X
36).

secondary cysts. This is the most important evidence
supporting the idea that mucosal surfaces are not suitable
for formation of the secondary echinococcosis (4).
Peritoneal surfaces that have been exposed are a good
environment for the development of secondary
echinococcosis (1, 2, 4, 7, 12, 22). The incidence of
peritoneal cyst development was found to be 80% in this
study. This result supports the idea that the peritoneal
cavity is a good environment for secondary hydatidosis.
On the other hand, there are contradictory findings
and opinions regarding the development of secondary
cysts in the pleural cavity. While several authors accept
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Table 2.

Antibody titrations measured by indirect hemoglutination test.

Rabbits No:
Fourth week
Fifteenth week

Table 3.

1

2

3

4

5

6

7

8

9

10

1/8
1/8

1/4
1/8

1/4
1/6

1/8
1/8

1/6
1/32

1/8
1/16

1/8
1/32

1/4

1/8
1/8

1/8

Antibody titrations measured by indirect florescein antibody test.

Rabbits No:
Fourth week
Fifteenth week

1

2

3

4

5

6

7

8

9

10

1/8
1/16

1/4
1/8

1/16
1/128

1/8
1/8

1/32
1/128

1/32
1/128

1/8
1/16

1/4
1/8

1/16
1/16

1/8
1/16

the possibility of secondary echinococcosis in the pleural
cavity, others dispute this (1, 12, 15-17, 22, 23 ).
Authors such as Dew (24), Hankins (25), and Yalav
(16) have suggested that cysts that rupture into the
peritoneal cavity can develop secondary cysts 2-10 years
later, but that scoleces which spread to the pleural cavity
can not develop a new cyst. Contrary to these authors,
Saidi (1), Mottaghian (12), Schiller (26) and Lewal (4)
reported that, in spite of some negativeness, secondary
cysts can develop in the pleural cavity. When a hydatid
cyst ruptured into the pleural cavity, serious clinical
conditions such as pneumothorax, pyopneumothorax or
empyema can develop. These are life threatening
situations which require immediate diagnosis and
treatment to reduce the likelihood of secondary cyst
development (12, 23, 27, 28 ). We found 30% cyst
development in the pleural cavity. On the basis of this
finding, we propose that secondary hydatid cyst
development in the pleural cavity is possible, although, it
is not a good environment for cyst development.
Saidi (1) suggested that the cysts which were opened
to the pleural cavity should be regarded as two different
types according to their origin, the liver or the lung. He
claims that, liver cysts are usually multivesicular and when
they are opened to the pleural cavity, they can develop
secondary cysts. Contrary to this, lung cysts are
univesicular, and when they rupture into the pleural
cavity, they can cause severe clinical pathologies such as
pneumothorax, peyopneumothorax and abscesses. These
situations prevent the development of secondary cysts in
the pleural cavity (17, 29). Although we excluded these
types of pathologies by injection of hydatid sand via a
needle, the degree of cyst development in the pleural

cavity is lower than in the peritoneal cavity. These results
suggested that other factors may be important in
reducing the number of secondary cysts in the pleural
cavity. Friction of pleural sheets during respiration might
be an important factor in preventing the scoleces
adhering to the pleural surface, and hence, in developing
new cysts. In this study, the cysts were located on the
lower parts of the lungs, which showed the least
expansion and friction during respiration. This
observation supports our conclusion.
Several serological tests have been used in the
diagnosis and follow-up of the development of hydatid
disease. The IHA and IFA tests are well-known, sensitive
and commonly used techniques in many laboratories (18,
19, 30, 31).
At the begining of the study, antibody could not be
exposed in the sera of the rabbits with each test. Hence,
it was thought that, the experimental animals were not
carriying hydatid disease or another disease giving cross
reaction with echinococcosis. Both tests gave positive
results correlating with the cyst number, cyst size and
cyst duration at the fourth and fifteenth weeks of the
study. The measurement of antibodies in lower
concentrations with the IFA test suggests that the IFA test
is more sensitive than the IHA test.
However, the presence of antibodies in the sera of
two rabbits without viable cyst is an interesting finding.
This may be due to antibodies developed against cystic
material injected at the begining of the study. On the basis
of this assumption, we propose that antibodies can be
detected in the sera of a patient after the treatment of
hydatid cyst until the cystic material disappears. Positive
results, after the treatment of a cyst, can cause confusion
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at follow-up about if the cyst is treated successfully,
whether the presence of another cyst has been
overlooked or early relapse has occured.

pleural cavity. In contrast, it is clear that the peritoneal
cavity is a good environment for the development of
secondary hydatid cysts.

In conclusion, secondary cyst development was shown
in a frequency of 80% in the peritoneal cavity and 30%
in the pleural cavity of the rabbits, by external inoculation
in this experimental study. The development of fewer
cysts in the pleural cavity supports the idea that this cavity
is not a good environment for secondary echinococcosis.
However, it should be kept in mind that secondary
echinococcosis is possible in the pleural cavity. The less
frequent occurences suggest that respiration may prevent
the adhering to adhere to the pleural surface, thereby
reducing their nourishment capacity. Technical difficulties
during the injection of hydatid fluid into the thorax might
be another factor preventing cyst development in the

The IHA and IFA tests gave positive results which
correlated to the cyst number, cyst size and cyst
progression. Hence, these two tests were found to be
valuable serological tools for the diagnosis of hydatid
disease and follow-up after treatment. They can also be
used as screening tests for echinococcosis in endemic
fields.
Correspondence author:
Mustafa ŞAHİN
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